Cargando…
Development of a DNA aptamer targeting IDO1 with anti-tumor effects
Immune checkpoint blockade has become an effective approach to reverse the immune tolerance of tumor cells. Indoleamine 2,3-dioxygenase 1 (IDO1) is frequently upregulated in many types of cancers and contributes to the establishment of an immunosuppressive cancer microenvironment, which has been tho...
Autores principales: | Zhu, Zhenyu, Yang, Zeliang, Zhu, Chuanda, Hu, Zixi, Jiang, Zhongyu, Gong, Jingjing, Yuan, Yuyao, Chen, Xi, Jin, Yan, Yin, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374466/ https://www.ncbi.nlm.nih.gov/pubmed/37520707 http://dx.doi.org/10.1016/j.isci.2023.107367 |
Ejemplares similares
-
Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-tumor Immunity
por: Zhang, Yujuan, et al.
Publicado: (2020) -
A sequentially triggered DNA nanocapsule for targeted drug delivery based on pH-responsive i-motif and tumor cell-specific aptamer
por: Yuan, Baoyin, et al.
Publicado: (2022) -
Imatinib potentiates anti-tumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
por: Balachandran, Vinod P., et al.
Publicado: (2011) -
Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers
por: Yang, Xiaomei, et al.
Publicado: (2019) -
Targeting the IDO1 pathway in cancer: from bench to bedside
por: Liu, Ming, et al.
Publicado: (2018)